These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 21216198)
1. Dutasteride for spinal and bulbar muscular atrophy. Banno H; Katsuno M; Suzuki K; Sobue G Lancet Neurol; 2011 Feb; 10(2):113-5. PubMed ID: 21216198 [No Abstract] [Full Text] [Related]
2. A severe phenotype of Kennedy disease associated with a very large CAG repeat expansion. Madeira JLO; Souza ABC; Cunha FS; Batista RL; Gomes NL; Rodrigues AS; Mennucci de Haidar Jorge F; Chadi G; Callegaro D; Mendonca BB; Costa EMF; Domenice S Muscle Nerve; 2018 Jan; 57(1):E95-E97. PubMed ID: 28877561 [No Abstract] [Full Text] [Related]
3. Molecular pathophysiology and disease-modifying therapies for spinal and bulbar muscular atrophy. Katsuno M; Banno H; Suzuki K; Adachi H; Tanaka F; Sobue G Arch Neurol; 2012 Apr; 69(4):436-40. PubMed ID: 22158719 [TBL] [Abstract][Full Text] [Related]
4. Kennedy's disease (spinal and bulbar muscular atrophy): a clinically oriented review of a rare disease. Breza M; Koutsis G J Neurol; 2019 Mar; 266(3):565-573. PubMed ID: 30006721 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of dutasteride in patients with spinal and bulbar muscular atrophy: a randomised placebo-controlled trial. Fernández-Rhodes LE; Kokkinis AD; White MJ; Watts CA; Auh S; Jeffries NO; Shrader JA; Lehky TJ; Li L; Ryder JE; Levy EW; Solomon BI; Harris-Love MO; La Pean A; Schindler AB; Chen C; Di Prospero NA; Fischbeck KH Lancet Neurol; 2011 Feb; 10(2):140-7. PubMed ID: 21216197 [TBL] [Abstract][Full Text] [Related]
6. Correlation between the CAG repeat size and electrophysiological findings in patients with spinal and bulbar muscular atrophy. Kim H; Lim YM; Lee EJ; Oh YJ; Kim KK Muscle Nerve; 2018 Apr; 57(4):683-686. PubMed ID: 28972672 [TBL] [Abstract][Full Text] [Related]
7. Kennedy's disease: clinical significance of tandem repeats in the androgen receptor. Zajac JD; Fui MN Adv Exp Med Biol; 2012; 769():153-68. PubMed ID: 23560310 [TBL] [Abstract][Full Text] [Related]
14. Spinal and bulbar muscular atrophy: a motoneuron or muscle disease? Jordan CL; Lieberman AP Curr Opin Pharmacol; 2008 Dec; 8(6):752-8. PubMed ID: 18775514 [TBL] [Abstract][Full Text] [Related]
15. Phenotypic differences in a large family with Kennedy's disease from the Middle Black Sea region of Turkey. Karaer H; Kaplan Y; Kurt S; Gundogdu A; Erdoğan B; Başak NA Amyotroph Lateral Scler; 2010; 11(1-2):148-53. PubMed ID: 20184516 [TBL] [Abstract][Full Text] [Related]
17. A case of spinal and bulbar muscular atrophy with high-stage and high-Gleason Score prostate cancer responded to maximal androgen blockade therapy. Kosaka T; Miyajima A; Kikuchi E; Takahashi S; Suzuki N; Oya M J Androl; 2012; 33(4):563-5. PubMed ID: 21940987 [TBL] [Abstract][Full Text] [Related]
18. Kennedy's disease and partial androgen insensitivity syndrome. Report of 4 cases and literature review. Valera Yepes R; Virgili Casas M; Povedano Panades M; Guerrero Gual M; Villabona Artero C Endocrinol Nutr; 2015 May; 62(5):224-30. PubMed ID: 25857692 [TBL] [Abstract][Full Text] [Related]
19. Role of androgen receptor polyQ chain elongation in Kennedy's disease and use of natural osmolytes as potential therapeutic targets. Kumar R IUBMB Life; 2012 Nov; 64(11):879-84. PubMed ID: 23024039 [TBL] [Abstract][Full Text] [Related]
20. Pathogenesis and molecular targeted therapy of spinal and bulbar muscular atrophy (SBMA). Banno H; Katsuno M; Suzuki K; Tanaka F; Sobue G Cell Tissue Res; 2012 Jul; 349(1):313-20. PubMed ID: 22476656 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]